Sunitinib-induced subungual splinter haemorrhage and acral erythema.
Nakamura
Motonobu
M
Miyachi
Yoshiki
Y
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005385:Fingers / Q000473:pathology; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D009260:Nail Diseases / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*; D000077210:Sunitinib
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib